Home - Keepsthefact.com

Adapting to the Future: How AI is Reshaping the Freelance Landscape

ByfactkeepsJun 20, 202413 min read

With the rapid rise of artificial intelligence (AI), the freelance sector is changing and it is changing fast. Forty-seven percent…

Digital Marketing

The Future of Search: Embracing AI and Conversational Interactions

ByfactkeepsJul 13, 2024

Digital Marketing

How to do Twitter Marketing in 2022? – 5 Powerful Tips for Twitter Marketing

By@factkeppsDec 20, 2021

Trending Posts

US AI Regulation: Experts Debate Whether It’s Falling Behind

ByfactkeepsApr 14, 2025

$In a major breakthrough for mental health technology, Dartmouth researchers have unveiled Threrabot, an AI-powered therapy chatbot that has shown clinical results on par with traditional cognitive behavioral therapy (CBT). In its first clinical trial, Threrabot helped users experience a 51% reduction in depression symptoms and a 31% decrease in anxiety over an 8-week period — results that experts are calling “game-changing” for the future of accessible mental health care. The chatbot, which delivers cognitive therapy techniques through conversational engagement, was designed to simulate the tone, empathy, and guidance of a human therapist. What’s especially remarkable is that participants reportedly developed a strong emotional bond with Threrabot — often describing it as a trusted confidant. This suggests that the human need for connection and validation can, at least partially, be met through well-designed AI. "This is not about replacing therapists,” said one of the lead researchers. “It’s about expanding access to care, especially for those who don’t currently receive any.” Mental health care has long struggled with barriers like cost, stigma, and long wait times. According to the World Health Organization, nearly one billion people live with mental disorders globally, but the majority do not receive adequate treatment. AI therapy bots like Threrabot could help fill that gap by providing always-available, scalable support at a fraction of the cost. Similar efforts have been seen with chatbots like Woebot and Wysa, which use evidence-based frameworks like CBT and dialectical behavioral therapy (DBT) to guide users. However, Threrabot's clinical trial represents a new benchmark in measurable outcomes and user engagement. Despite the promise, experts urge caution. The effectiveness of AI therapy depends heavily on how it's designed, monitored, and integrated into broader care systems. Ethical concerns around data privacy, safety in crisis scenarios, and emotional over-reliance on machines remain unresolved. Still, the early success of Threrabot signals a paradigm shift. AI is no longer just an assistant in therapy — it’s becoming a credible therapeutic tool. With further research and responsible development, it could help democratize mental health care on a global scale. As mental health challenges continue to rise, Threrabot and similar innovations could be the beginning of a more inclusive, tech-assisted mental wellness ecosystem.$